Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts

Fig. 2

Pharmacokinetic assessment of 89Zr-T. a Blood curves derived from serial blood sampling. A mono-exponential fit, with formula y = 22.1e−0.012x (R2 = 0.92) yielded a blood clearance half-life of 75 h. b Biodistribution profile at 24, 72, 144, and 168 h post-injection of 89Zr-T obtained from dissected organs. JIMT-1 tumors are the only tissue showing a continuous uptake increase through time, while most non-specific organs harbor either a decline or a stable uptake in the same time interval

Back to article page